Fluzoparib Combined With Camrelizumab for Maintenance Treatment of Locally Advanced Non-small Cell Lung Cancer
Clinical trial NCT04828395 · UNKNOWN
Trial details
- NCT number
- NCT04828395
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-01
- Primary completion
- 2023-03-01
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.